ライフサイエンスコーパス: juvenile idiopathic arthritis

1 ciated with uveitis also are idiopathic (eg, juvenile idiopathic arthritis).

2 tones risk; and between immunoglobulin A and juvenile idiopathic arthritis).

3 been made in the measurement of outcomes in juvenile idiopathic arthritis.

4 t rheumatoid arthritis might have utility in juvenile idiopathic arthritis.

5 idity and mortality seen with systemic onset juvenile idiopathic arthritis.

6 redominantly in children with systemic onset juvenile idiopathic arthritis.

7 ry outcome measures in therapeutic trials in juvenile idiopathic arthritis.

8 ic arthritis (SoJIA) represents up to 20% of juvenile idiopathic arthritis.

9 diopathic uveitis or uveitis associated with juvenile idiopathic arthritis.

10 ophage activation syndrome in systemic onset juvenile idiopathic arthritis.

11 isk of lower respiratory tract infection and juvenile idiopathic arthritis.

12 omandibular joint arthritis in children with juvenile idiopathic arthritis.

13 11 years, range 4-16), of whom 37 (74%) had juvenile idiopathic arthritis.

14 edict temporomandibular joint involvement in juvenile idiopathic arthritis.

15 f S100A12 correlate with disease activity in juvenile idiopathic arthritis.

16 2001on the matter of uveitis associated with juvenile idiopathic arthritis.

17 as been used to treat children with systemic juvenile idiopathic arthritis.

18 he interleukin-1 signature in systemic onset juvenile idiopathic arthritis.

19 compromise the resolution of inflammation in juvenile idiopathic arthritis.

20 tionally is classified under the umbrella of juvenile idiopathic arthritis.

21 anti-citrullinated protein antibody-positive juvenile idiopathic arthritis.

22 anti-citrullinated protein antibody-positive juvenile idiopathic arthritis.

23 ocular morbidity of uveitis associated with juvenile idiopathic arthritis, aggressive therapies can

24 ackground rate of malignancy associated with juvenile idiopathic arthritis, although the impact of me

25 losing spondylitis, psoriatic arthritis, and juvenile idiopathic arthritis among the inflammatory joi

26 ed with biologic agents for the treatment of juvenile idiopathic arthritis and childhood-onset system

27 The diagnoses of juvenile idiopathic arthritis and childhood-onset system

28 recognized in children and young adults with juvenile idiopathic arthritis and is multifactorial in o

29 rsity before and after HSCT in patients with juvenile idiopathic arthritis and juvenile dermatomyosit

30 aired in a large proportion of children with juvenile idiopathic arthritis and other rheumatic diseas

31 de has been utilized to treat systemic onset juvenile idiopathic arthritis and related autoinflammato

32 tive diseases, significantly most similar to juvenile idiopathic arthritis and significantly least si

33 ary biliary cirrhosis, rheumatoid arthritis, juvenile idiopathic arthritis, and alopecia areata.

34 itions, and preliminary quality measures for juvenile idiopathic arthritis, and cites examples of qua

35 hildhood-onset systemic lupus erythematosus, juvenile idiopathic arthritis, and juvenile dermatomyosi

36 hildhood-onset systemic lupus erythematosus, juvenile idiopathic arthritis, and juvenile dermatomyosi

37 60% were female, approximately half had juvenile idiopathic arthritis, and most were treated wit

38 ty of life in large cohorts of children with juvenile idiopathic arthritis are important in guiding i

39 tic reports of the use of bisphosphonates in juvenile idiopathic arthritis are welcome additions to t

40 re rheumatic diseases, most notably systemic juvenile idiopathic arthritis, are at risk for MAS.

41 ase pathogenesis of lupus and systemic onset juvenile idiopathic arthritis as well as related conditi

42 ctors, and course of ocular hypotony (OH) in juvenile idiopathic arthritis-associated uveitis (JIAU).

43 ses were birdshot chorioretinopathy (n = 3), juvenile idiopathic arthritis-associated uveitis (n = 3)

44 -Hispanic African-American children with non-juvenile idiopathic arthritis-associated uveitis may hav

45 Many cases of juvenile idiopathic arthritis-associated uveitis, many c

46 setting of certain forms of uveitis, such as juvenile idiopathic arthritis-associated uveitis, remain

47 As the pathogenesis of juvenile idiopathic arthritis becomes better understood,

48 the incidence of malignancy associated with juvenile idiopathic arthritis, both with and without tre

49 related protein-14 (S100A9) in children with juvenile idiopathic arthritis can indicate clinically oc

50 Juvenile idiopathic arthritis continues to provide probl

51 A 46-year-old man with juvenile idiopathic arthritis developed a pruritic cutan

52 lity of new medications for the treatment of juvenile idiopathic arthritis has made the accurate asse

53 ith rheumatoid factor positive polyarticular juvenile idiopathic arthritis, have the greatest deficit

54 In juvenile idiopathic arthritis, heat shock proteins have

55 with seronegative spondyloarthropathies and juvenile idiopathic arthritis; however, etanercept has f

56 The most common causes were juvenile idiopathic arthritis in 39 patients, pars plani

57 on electrode, aiming at the diagnosis of the juvenile idiopathic arthritis in real serum samples.

58 tumor necrosis factor-alpha inhibitors has a juvenile idiopathic arthritis indication.

59 The armamentarium for treatment of juvenile idiopathic arthritis is expanding at a rapid ra

60 tivity in the development of osteoporosis in juvenile idiopathic arthritis is the focus of several st

61 ), fulfillment of criteria for >1 subtype of juvenile idiopathic arthritis (JIA) (5%), and HLA-B27 in

62 about exercise therapy in the management of juvenile idiopathic arthritis (JIA) along with activity

63 dministered to children and adolescents with juvenile idiopathic arthritis (JIA) and pediatric inflam

64 ination on disease activity in patients with juvenile idiopathic arthritis (JIA) are matters of conce

65 Juvenile idiopathic arthritis (JIA) can persist through

66 Juvenile idiopathic arthritis (JIA) comprises several cl

67 Uveitis associated with juvenile idiopathic arthritis (JIA) continues to blind s

68 olyarticular rheumatoid factor (RF)-negative juvenile idiopathic arthritis (JIA) due to the presence

69 loci in oligoarthritis in UK Caucasians with juvenile idiopathic arthritis (JIA) has not been describ

70 Patients with systemic juvenile idiopathic arthritis (JIA) have arthritis, quot

71 The chronicity of juvenile idiopathic arthritis (JIA) into adulthood and a

72 ciations for Rheumatology criteria parse out juvenile idiopathic arthritis (JIA) into seven groups, w

73 Juvenile idiopathic arthritis (JIA) is a chronic rheumat

74 Juvenile idiopathic arthritis (JIA) is a heterogeneous g

75 Juvenile idiopathic arthritis (JIA) is a wide group of d

76 Juvenile idiopathic arthritis (JIA) is an autoimmune dis

77 Systemic juvenile idiopathic arthritis (JIA) is an autoinflammato

78 predict response to therapy in polyarticular juvenile idiopathic arthritis (JIA) is an important issu

79 Assessment of this association in juvenile idiopathic arthritis (JIA) is complicated by ag

80 Systemic juvenile idiopathic arthritis (JIA) is frequently associ

81 Juvenile Idiopathic Arthritis (JIA) is one of the most c

82 Systemic juvenile idiopathic arthritis (JIA) is the most severe s

83 The pathogenesis of juvenile idiopathic arthritis (JIA) is thought to involv

84 In juvenile idiopathic arthritis (JIA) patients, we have pr

85 Juvenile idiopathic arthritis (JIA) refers to a collecti

86 Eight children with juvenile idiopathic arthritis (JIA) served as controls.

87 Subtypes of juvenile idiopathic arthritis (JIA) share phenotypic fea

88 concentrations in a cohort of patients with juvenile idiopathic arthritis (JIA) to determine the pre

89 aluations of the well-being of children with juvenile idiopathic arthritis (JIA) typically rely on pa

90 amily in which 9 members were diagnosed with juvenile idiopathic arthritis (JIA) was ascertained.

91 n this work, a novel biosensor for detecting juvenile idiopathic arthritis (JIA) was developed based

92 y reported to be a characteristic feature of juvenile idiopathic arthritis (JIA), but the relevance o

93 chip array to analyze 2,816 individuals with juvenile idiopathic arthritis (JIA), comprising the most

94 in patients with the most common subtypes of juvenile idiopathic arthritis (JIA), IgM rheumatoid fact

95 diseases in the UK population, including RA, juvenile idiopathic arthritis (JIA), psoriasis, psoriati

96 ultifactorial diseases, including autoimmune juvenile idiopathic arthritis (JIA), result from a compl

97 In juvenile idiopathic arthritis (JIA), there are now more

98 S on children with the polyarticular form of juvenile idiopathic arthritis (JIA), using 2 independent

99 association study of Caucasian patients with juvenile idiopathic arthritis (JIA), we have previously

100 t evidence from the literature pertaining to juvenile idiopathic arthritis (JIA)-associated uveitis.

101 ciation between cow's milk allergy (CMA) and juvenile idiopathic arthritis (JIA).

102 e gene that causes diastrophic dysplasia, in juvenile idiopathic arthritis (JIA).

103 e and are associated with innate immunity in juvenile idiopathic arthritis (JIA).

104 ge activation syndrome complicating systemic juvenile idiopathic arthritis (JIA).

105 RhMDT) assessment for children with incident juvenile idiopathic arthritis (JIA).

106 h the fever and disease activity of systemic juvenile idiopathic arthritis (JIA).

107 umatoid arthritis (RA), and 19 subjects with juvenile idiopathic arthritis (JIA).

108 ears further defining the pathophysiology of juvenile idiopathic arthritis (JIA).

109 1 is pivotal in the pathogenesis of systemic juvenile idiopathic arthritis (JIA).

110 ociated with a rare group of diseases called juvenile idiopathic arthritis (JIA).

111 and autoantigen in a subset of children with juvenile idiopathic arthritis (JIA).

112 l antibody, is effective in the treatment of juvenile idiopathic arthritis (JIA).

113 trated that there is familial aggregation of juvenile idiopathic arthritis (JIA).

114 ate (MTX) are unpredictable in patients with juvenile idiopathic arthritis (JIA).

115 and autoantigen in a subset of children with juvenile idiopathic arthritis (JIA).

116 is abundant in the synovia of patients with juvenile idiopathic arthritis (JIA).

117 is (RA) and other rheumatic diseases such as juvenile idiopathic arthritis (JIA).

118 il activation in children with polyarticular juvenile idiopathic arthritis (JIA).

119 MTX) in children with selected categories of juvenile idiopathic arthritis (JIA).

120 thin the IL2RA/CD25 gene are associated with juvenile idiopathic arthritis (JIA).

121 Systemic diagnoses with juvenile idiopathic arthritis (JIA; adjusted hazard rati

122 associated with increased risk for systemic juvenile idiopathic arthritis, leprosy and Crohn's disea

123 in weight-bearing cartilage in patients with juvenile idiopathic arthritis may help with early detect

124 approved dosage for rheumatoid arthritis and juvenile idiopathic arthritis, may be an effective treat

125 tients with uveitic glaucoma associated with juvenile idiopathic arthritis (n = 20), idiopathic uveit

126 NK cells isolated from the synovial fluid of juvenile idiopathic arthritis patients failed to inhibit

127 ophage activation syndrome in systemic onset juvenile idiopathic arthritis patients.

128 ed muscle mass and abnormal bone geometry in juvenile idiopathic arthritis patients.

129 +) monocytes exposed to plasma from systemic juvenile idiopathic arthritis patients.

130 (SF) from patients with osteoarthritis (OA), juvenile idiopathic arthritis, psoriatic arthritis (PsA)

131 The majority of patients with juvenile idiopathic arthritis-related uveitic glaucoma r

132 re was achieved in the eyes of patients with juvenile idiopathic arthritis-related uveitis glaucoma w

133 ing of the risk factors for poor outcomes in juvenile idiopathic arthritis-related uveitis.

134 e far more costly than that of adult SLE and juvenile idiopathic arthritis reported in the literature

135 eitis in children are highlighted, including juvenile idiopathic arthritis, sarcoidosis and Behcet's

136 ned from the synovial fluid of patients with juvenile idiopathic arthritis show marked downregulation

137 rs most frequently in patients with systemic juvenile idiopathic arthritis (SJIA) and systemic lupus

138 Systemic juvenile idiopathic arthritis (SJIA) is an inflammatory

139 When applied to systemic juvenile idiopathic arthritis (sJIA), an autoinflammator

140 escent from the United Kingdom with systemic juvenile idiopathic arthritis (sJIA), with the GG genoty

141 his review summarizes biomarkers in systemic juvenile idiopathic arthritis (sJIA).

142 y, is most strongly associated with systemic juvenile idiopathic arthritis (SJIA).

143 Systemic onset juvenile idiopathic arthritis (SoJIA) encompasses approx

144 Systemic onset juvenile idiopathic arthritis (SoJIA) represents up to 2

145 ation is now also reported in systemic onset juvenile idiopathic arthritis (SoJIA).

146 pivotal trial of infliximab in polyarticular juvenile idiopathic arthritis suggested efficacy, but th

147 osed rheumatic diseases in children, such as juvenile idiopathic arthritis, systemic lupus erythemato

148 The disorders reviewed are juvenile idiopathic arthritis, systemic lupus erythemato

149 in treating chronic uveitis associated with juvenile idiopathic arthritis than etanercept.

150 more frequent manifestation in patients with juvenile idiopathic arthritis than previously believed,

151 In the inflammatory site in human juvenile idiopathic arthritis, the CD39(+)Foxp3(-) popul

152 charged with developing quality measures for juvenile idiopathic arthritis; thus, there is a commitme

153 iments, the addition of NGF to LPS-activated juvenile idiopathic arthritis to both mononuclear cells

154 ortant; no child should be labeled as having juvenile idiopathic arthritis unless there is a clear hi

155 ciated at the inflamed site in patients with juvenile idiopathic arthritis, which led us to question

156 In patients with juvenile idiopathic arthritis who do not respond to oral

157 ic illness and rheumatic conditions, such as juvenile idiopathic arthritis, who demonstrated no socia